Medidata Spurs Innovation with Developer Central



SYSTEMS INTEGRATION

By Ann Neuer

Nov. 3, 2008Medidata Solutions is launching Medidata Developer Central, an online community to support sponsors in their efforts to integrate various clinical trial solutions with Medidata Rave, the company’s electronic data capture and clinical data management platform. Medidata Developer Central is intended to foster innovation around the Rave platform and is a free service available to users of the recently available Medidata Rave Web Services Application Programming Interface (API), as well as those in the midst of adopting or evaluating Rave Web Services API.

In going live with Medidata Developer Central, Glen de Vries, president, says, “Our customers are demanding the ability to leverage Rave across a broader set of clinical processes by integrating with interactive voice response (IVR), electronic patient reported outcomes (ePRO), and clinical trial management tools. The intent is to maximize and protect their investments in clinical trial technology.”

Glen de Vries
Glen de Vries
The Developer Central community will likely be made up of engineers or product managers responsible for integrating Rave with various technologies. As de Vries explains, developers will have access to a live copy of the Rave platform, searchable documentation, white papers, and guides, essentially all the Web-based tools needed to get started. “While developing at their desks, developers will be able to send data back and forth. You can be testing your own code,” says de Vries.  Members of the community will have an interactive forum where they can converse with and gain access to best practices from developers who are working on the same platform.

Medidata is looking to Developer Central to become a rich community. Over time, the company expects resulting innovations to drive the industry toward a seamless electronic clinical research environment with real-time, inbound and outbound data that adheres to Clinical Data Interchange Standards Consortium (CDISC) data standards. To jumpstart the process, Medidata became certified earlier this year on all eight CDISC Operational Data Model (ODM) use cases for importing and exporting clinical study data. This means that during the integration process, clients have access to Medidata’s ODM standards for all of the various components of their e-clinical process.

During the startup of Developer Central, a number of developers from clinical technology providers stepped forward to become pilot members. One of them, PHT Corp., a provider of ePRO solutions, used the Rave Web Services API to integrate several patient diaries from PHT’s LogPad System into Rave, a demo project that took just six days. Now PHT is aiming to leverage Developer Central’s community and resources to further enhance this solution by making the integration scalable and reliable across a wide range of scenarios.

Philip Lee
Philip Lee
“We did the integration at record pace,” says Philip Lee, president and CEO of PHT. “The old way of integrating would have taken five to 10 times as long as it would have required us to create the electronic case report forms in Rave using their design tool, then we would have had to map their data fields into our database, and then set up the technical mechanism for uploading the data to Rave on a periodic basis.” Lee explains that in addition, the old method required extensive testing, as it constituted a custom integration project.

As integration continues, and with Medidata Developer Central becoming operational, the move toward extensive use of repeatable standards-based processes and forms will expand, saving precious time. “These efforts will greatly accelerate the ability of our clients to get value out of our platform,” says de Vries. 
________________________________

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .